Login
Breaking News
Broadcom   RH   Adobe   Chewy   Dave & Buster's   Macy's   GE Vernova   Uber Technologies   GM  

Vaxxinity inc.

Biotechnology:-Biological-Products-(No-Diagnostic-Substances)

VAXX


1717 Main Street
Dallas , TX 75201
Website
Investor Relation

Executive/
Director

Executive/Director

Links

10K
10Q
Prospectus

Price

  • Last Close
  • $ 0.23
    $ -0.24 -52.03 %
    Apr 19, 2024
  • 52-Week High/Low
  • $2.09 - $0.22
  • YTD
  • -73.5%

  • Trading Volume
  • 13,135
  • Market Cap Full
  • $ 29M
  • Shares Outstanding
  • 126.1M
    Mar 31, 2023

Returns +
Q

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -23.4% 62.1% -15.5%
Q2 - - - - - - - -63.5% 11% -2.5%
Q3 - - - - - - - 26.1% -45.6% -
Q4 - - - - - - -66.1% -29.3% -33.1% -

Returns +
M
J F M A M J J A S O N D
2024 -16.5% 20.4% -16% -3.6% - - - - - - - -
2023 185.7% -41.3% -3.4% -6.2% -16.4% 41.6% 6.8% -24.9% -32.2% -16.1% -26.3% 0.2%

Returns +
A
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-75%-39%-74%

Earnings

2021 2022 2023
Q1 -0.47 -0.15 -0.15
Q2 -0.39 -0.14 -0.11
Q3 -0.44 -0.15 -0.10
Q4 -0.49 -0.16 -
A -1.8 -0.6 -0.36

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Outstanding Shares
(In Millions) +

Jan 16, 2024
2021 2022 2023
Mar - 125.7 126.1
Jun - - -
Sep - - -
Dec 76.6 125.9 -

Financial Statements
+

Annual
Download

SEC Filings

Date Form Type SEC Filings
May 2, 2024 EFFECT Financial Statements
Apr 29, 2024 25 Financial Statements
Apr 29, 2024 10-K/A Financial Statements
Apr 29, 2024 PRE 14C Financial Statements
Apr 19, 2024 8-K Financial Statements
Dec 1, 2023 8-K Financial Statements
Nov 30, 2023 144 Financial Statements
Nov 29, 2023 144 Financial Statements
Nov 8, 2023 10-Q Financial Statements
Nov 3, 2023 4 Financial Statements

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Total Asset Turnover - - - - -
Fixed Asset Turnover - - 0.1 - -
Leverage
Debt Ratio 0.1 0.1 0.3 - -
Debt – Equity Ratio 0.2 0.1 -0.1 - -
Interest Coverage 76 -10.4 -4 - -
Equity multiplier 0.2 0.1 -0.1 - -
Data Sources Disclaimer